ChromoGenics AB

Symbol: CHRO.ST

STO

7

SEK

Market price today

  • -0.4925

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 28.87M

    MRK Cap

  • 0.00%

    DIV Yield

ChromoGenics AB (CHRO-ST) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

-0.74%

Operating Profit Margin

-3.67%

Net Profit Margin

-3.91%

Return on Assets

-0.38%

Return on Equity

-0.99%

Return on Capital Employed

-0.45%

Company general description and statistics

Sector: Industrials
Industry: Building Products & Equipment
CEO:Fredrik Franding
Full-time employees:32
City:Uppsala
Address:Ullforsgatan 15
IPO:2017-03-23
CIK:

ChromoGenics AB provides glass products that controls heat and light transmission in Sweden. It offers dynamic and static glasses, and colored solar facades under the ConverLight name. The company was founded in 2003 and is headquartered in Uppsala, Sweden.

General Outlook

When we look at how much money they make before expenses, they keep -0.745% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -3.675%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -3.912%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.384% return, is a testament to ChromoGenics AB's adeptness in optimizing resource deployment. ChromoGenics AB's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.988%. Furthermore, the proficiency of ChromoGenics AB in capital utilization is underscored by a remarkable -0.448% return on capital employed.

Stock Prices

ChromoGenics AB's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $7.26, while its low point bottomed out at $6.74. This variance in figures offers investors a lucid insight into the roller-coaster ride that is ChromoGenics AB's stock market.

Liquidity Ratios

Analyzing CHRO.ST liquidity ratios reveals its financial health of the firm. The current ratio of 108.76% gauges short-term asset coverage for liabilities. The quick ratio (71.57%) assesses immediate liquidity, while the cash ratio (28.97%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio108.76%
Quick Ratio71.57%
Cash Ratio28.97%

Profitability Ratios

CHRO.ST profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -384.79% underscores its earnings before tax deductions. The effective tax rate stands at -1.70%, revealing its tax efficiency. The net income per EBT, 101.68%, and the EBT per EBIT, 104.71%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -367.47%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-384.79%
Effective Tax Rate-1.70%
Net Income per EBT101.68%
EBT per EBIT104.71%
EBIT per Revenue-367.47%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.09, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding72
Days of Inventory Outstanding156
Operating Cycle467.81
Days of Payables Outstanding42
Cash Conversion Cycle425
Receivables Turnover1.17
Payables Turnover8.60
Inventory Turnover2.34
Fixed Asset Turnover0.14
Asset Turnover0.10

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -10.21, and free cash flow per share, -10.34, depict cash generation on a per-share basis. The cash per share value, 1.92, showcases liquidity position. Lastly, the operating cash flow sales ratio, -3.08, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-10.21
Free Cash Flow per Share-10.34
Cash per Share1.92
Operating Cash Flow Sales Ratio-3.08
Free Cash Flow to Operating Cash Flow Ratio1.01
Cash Flow Coverage Ratio-0.63
Short Term Coverage Ratio-211.53
Capital Expenditure Coverage Ratio-83.03
Dividend Paid and Capex Coverage Ratio-83.03

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 48.02%, highlights its total liabilities relative to assets. With a debt-equity ratio of 1.56, we discern the balance between debt and equity financing. The long-term debt to capitalization, 60.91%, and total debt to capitalization, 60.98%, ratios shed light on its capital structure. An interest coverage of -11.94 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio48.02%
Debt Equity Ratio1.56
Long Term Debt to Capitalization60.91%
Total Debt to Capitalization60.98%
Interest Coverage-11.94
Cash Flow to Debt Ratio-0.63
Company Equity Multiplier3.25

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 5.15, provides a glimpse into top-line earnings distributed across each share. Net income per share, -19.81, reflects the portion of profit attributed to each share. The book value per share, 16.13, represents the net asset value distributed per share, while the tangible book value per share, 13.02, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share5.15
Net Income Per Share-19.81
Book Value Per Share16.13
Tangible Book Value Per Share13.02
Shareholders Equity Per Share16.13
Interest Debt Per Share26.83
Capex Per Share-0.05

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -25.27%, indicates top-line expansion, while the gross profit growth, -1635.76%, reveals profitability trends. EBIT growth, 11.99%, and operating income growth, 11.99%, offer insights into operational profitability progression. The net income growth, 6.88%, showcases bottom-line expansion, and the EPS growth, -2258.33%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-25.27%
Gross Profit Growth-1635.76%
EBIT Growth11.99%
Operating Income Growth11.99%
Net Income Growth6.88%
EPS Growth-2258.33%
EPS Diluted Growth-2258.33%
Weighted Average Shares Growth-96.05%
Weighted Average Shares Diluted Growth-96.05%
Operating Cash Flow Growth31.16%
Free Cash Flow Growth36.23%
5-Year Revenue Growth per Share-0.30%
3-Year Revenue Growth per Share-94.68%
10-Year Operating CF Growth per Share86.33%
5-Year Operating CF Growth per Share46.58%
3-Year Operating CF Growth per Share95.32%
10-Year Net Income Growth per Share78.58%
5-Year Net Income Growth per Share41.28%
3-Year Net Income Growth per Share95.60%
10-Year Shareholders Equity Growth per Share-29.65%
5-Year Shareholders Equity Growth per Share188.00%
3-Year Shareholders Equity Growth per Share-97.98%
Receivables Growth-0.49%
Inventory Growth-0.24%
Asset Growth-13.83%
Book Value per Share Growth1434.52%
Debt Growth4.27%
R&D Expense Growth-100.00%
SGA Expenses Growth67.12%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 77,449,123, captures the company's total value, considering both debt and equity. Income quality, 0.78, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 7.67%, indicates the value of non-physical assets, and capex to operating cash flow, 0.33%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value77,449,123
Income Quality0.78
Intangibles to Total Assets7.67%
Capex to Operating Cash Flow0.33%
Capex to Revenue-1.00%
Capex to Depreciation-3.04%
Graham Number84.79
Return on Tangible Assets-40.86%
Graham Net Net-27.25
Working Capital2,396,000
Tangible Asset Value34,508,000
Net Current Asset Value-64,225,000
Invested Capital2
Average Receivables11,686,500
Average Payables5,691,000
Average Inventory10,186,000
Days Sales Outstanding312
Days Payables Outstanding16
Days of Inventory On Hand58
ROIC-46.21%
ROE-1.23%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.61, and the price to book ratio, 0.61, reflect the market's valuation relative to the company's book value. The price to sales ratio, 3.10, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -0.99, and price to operating cash flows, -0.62, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio0.61
Price to Book Ratio0.61
Price to Sales Ratio3.10
Price Cash Flow Ratio-0.62
Enterprise Value Multiple0.37
Price Fair Value0.61
Price to Operating Cash Flow Ratio-0.62
Price to Free Cash Flows Ratio-0.99
Price to Tangible Book Ratio0.43
Enterprise Value to Sales5.68
Enterprise Value Over EBITDA-1.68
EV to Operating Cash Flow-1.90
Earnings Yield-282.97%
Free Cash Flow Yield-220.82%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of ChromoGenics AB (CHRO.ST) on the STO in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -0.493 in 2024.

What is the ticker symbol of ChromoGenics AB stock?

The ticker symbol of ChromoGenics AB stock is CHRO.ST.

What is company IPO date?

IPO date of ChromoGenics AB is 2017-03-23.

What is company current share price?

Current share price is 7.000 SEK.

What is stock market cap today?

The market cap of stock today is 28874790.000.

What is PEG ratio in 2024?

The current 0.000 is 0.000 in 2024.

What is the number of employees in 2024?

In 2024 the company has 32.